Clinical Trial

A Real-World Study About Anemia in Chronic Kidney Disease in China(DASHENG)

Study acronym: DASHENG
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Anemia affects the quality of life of CKD patients and increases the risk of CKD progression. we conducted a real-world study on patients with anemia in CKD to analyze the disease characteristics and treatment in Chinese patients with CKD-anemia.
Trial Details
NCT Number NCT07098416
Lead Sponsor Wei Chen
Conditions Anemia in Chronic Kidney Disease
Enrollment 20,000 participants
Start Date 2025-08-01
Primary Completion 2026-08-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-01